TrialAmerican heart journal2007

Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome.

Ronald V Lacro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.